E. C. Little

发表

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy

D J Cole, A Rait, E. Chang, 2013, Cancer Gene Therapy.

PAX3 and ETS1 synergistically activate MET expression in melanoma cells

E. C. Little, D. Lang, Jennifer D. Kubic, 2014, Oncogene.

Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer

R. Salgia, P. Grippo, E. C. Little, 2017, Oncology letters.

Cell Responses to Self and Tumor Tissue The Inducible Costimulator Augments Tc17

M. Rubinstein, D. Cole, Jacob S. Bowers, 2015 .

Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer.

P. Watson, D. Watson, D. Cole, 2012, The Journal of surgical research.

The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells

P. Watson, D. Watson, D. Cole, 2016, Oncogenesis.

PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma*

R. Salgia, A. Aplin, E. C. Little, 2015, The Journal of Biological Chemistry.

FOXD3 Promotes PAX3 Expression in Melanoma Cells

E. C. Little, D. Lang, Jennifer D. Kubic, 2016, Journal of cellular biochemistry.

Targeting Pan-ETS Factors Inhibits Melanoma Progression

E. C. Little, Jennifer La, J. Bhawan, 2021, Cancer Research.

The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue

S. Mehrotra, C. Paulos, M. Rubinstein, 2015, The Journal of Immunology.

The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma

E. C. Little, D. Lang, Jason W Lui, 2019, Journal of Cancer.